The company’s revenues rose sharply aided by an increase in procedures and systems placements, led by the da Vinci system
At $1.05 billion, revenues were higher by 17% compared to the fourth quarter of 2017. The top line was in line with the company’s preliminary estimates and slightly above the analysts’ forecast.
Revenues of the Instruments and accessories segment climbed 18% year-on-year to $539.3 million, while Systems revenue moved up 20% to $340.6 million. There was an 11% growth in Services revenue to $166.6 million.
Also see: Intuitive Surgical Q4 2018 Earnings Conference Call Transcript
During the quarter, there was a 19% annual growth in da Vinci procedures globally. A total of 290 da Vinci Surgical Systems, the company’s flagship product, were shipped, compared to 216 in the year-ago quarter.
Shares of Intuitive Surgical gained about 21% in the last year, and lost about 7% since they hit a record high in September 2018. The stock dropped about 4% in the after-hours Thursday, after closing the regular session higher.